The aim of this study was to evaluate the association between chronic obstructive pulmonary disease (COPD) and nontuberculosis mycobacterium (NTM) disease.
We used data from the National Health Insurance Research Database of Taiwan in this study. The NTM cohort contained 3,005 patients, and each case was randomly frequency matched by age, sex, income, occupation, and index year with four people from the general population without NTM infections. Multivariate Cox proportional hazards regression was used to calculate adjusted hazard ratios (aHR) of COPD in the NTM cohort compared with the non-NTM cohort.
The incidence of COPD was 3.08-fold higher (21.75 vs. 6.11 per 1,000 person-years) in the NTM cohort than in the non-NTM cohort. The aHR of COPD comparing the NTM cohort with the non-NTM cohort was 3.57 (95 % CI 2.56–4.97) for women and 2.89 (95 % CI 2.31–3.61) for men. The aHR of COPD was higher in the patients with NTM infection and a comorbidity such as bronchopneumonia, pneumonia, diabetes, asthma, and heart disease. The Mycobacterium avium-intracellulare complex group (MAC) and the non-MAC group were isolated in the NTM cohort. The MAC group had a higher aHR of COPD than the non-NTM cohort (aHR = 3.72, 95 % CI 2.94–4.72). The cumulative incidence of COPD in the NTM cohort was higher than in the non-NTM cohort (P < 0.0001, log rank test).
Physicians should be aware of indolent NTM disease that increases the risk of COPD.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
US Burden of Disease Collaborators (2013) The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA 310(6):591–608
Reid PT, Sallenave JM (2003) Cytokines in the pathogenesis of chronic obstructive pulmonary disease. Curr Pharm Des 9:25–38
Han MK, Agusti A, Calverley PM, Celli BR, Criner G et al (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182:598–604
O’Donnell AE (2011) Bronchiectasis in patients with COPD: a distinct COPD phenotype? Chest 140:1107–1108
McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM et al (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365:1567–1575
Timmins SC, Diba C, Farrow CE, Schoeffel RE, Berend N et al (2012) The relationship between airflow obstruction, emphysema extent, and small airways function in COPD. Chest 142:312–319
Funk GC, Bauer P, Burghuber OC, Fazekas A, Hartl S et al (2013) Prevalence and prognosis of COPD in critically ill patients between 1998 and 2008. Eur Respir J 41:792–799
Kubo K, Yamazaki Y, Masubuchi T, Takamizawa A, Yamamoto H et al (1998) Pulmonary infection with Mycobacterium avium-intracellulare leads to air trapping distal to the small airways. Am J Respir Crit Care Med 158:979–984
Song JW, Koh WJ, Lee KS, Lee JY, Chung MJ et al (2008) High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. AJR Am J Roentgenol 191:1070
Jeong YJ, Lee KS, Koh WJ, Han J, Kim TS et al (2004) Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology 231:880–886
Fjallbrant H, Akerstrom M, Svensson E, Andersson E (2013) Hot tub lung: an occupational hazard. Eur Respir Rev 22:88–90
Selman-Lama M, Perez-Padilla R (1993) Airflow obstruction and airway lesions in hypersensitivity pneumonitis. Clin Chest Med 14:699–714
Hansell DM, Wells AU, Padley SP, Muller NL (1996) Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities. Radiology 199:123–128
Petersen H, Sood A, Meek PM, Shen X, Cheng Y et al (2014) Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by ACE inhibitor use. Chest. doi:10.1378/chest.13-0799
Andrejak C, Nielsen R, Thomsen VO, Duhaut P, Sorensen HT et al (2013) Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 68:256–262
Andrejak C, Thomsen VO, Johansen IS, Riis A, Benfield TL et al (2010) Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 181:514–521
Yeh CC, Wang HH, Chou YC, Hu CJ, Chou WH et al (2013) High risk of gastrointestinal hemorrhage in patients with epilepsy: a nationwide cohort study. Mayo Clin Proc 88:1091–1098
Thomson RM, Yew WW (2009) When and how to treat pulmonary non-tuberculous mycobacterial diseases. Respirology 14:12–26
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416
Ding LW, Lai CC, Lee LN, Hsueh PR (2006) Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997–2003. Epidemiol Infect 134:1060–1067
Park YS, Lee CH, Lee SM, Yang SC, Yoo CG et al (2010) Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis 14:1069–1071
Kim HS, Lee KS, Koh WJ, Jeon K, Lee EJ et al (2012) Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. Radiology 263:260–270
Ringshausen FC, Apel RM, Bange FC, de Roux A, Pletz MW et al (2013) Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011. BMC Infect Dis 13:231
Ringshausen FC, de Roux A, Pletz MW, Hamalainen N, Welte T et al (2013) Bronchiectasis-associated hospitalizations in Germany, 2005–2011: a population-based study of disease burden and trends. PLoS One 8:e71109
Stiefelhagen P (2008) COPD and pneumonia therapy in the elderly. What is different in aging lungs. MMW Fortschr Med 150:12–14
Naylor EJ, Bakstad D, Biffen M, Thong B, Calverley P et al (2007) Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease? Am J Respir Cell Mol Biol 37:135–143
Moghaddam SJ, Clement CG, De la Garza MM, Zou X, Travis EL et al (2008) Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am J Respir Cell Mol Biol 38:629–638
El-Solh AA, Nopper J, Abdul-Khoudoud MR, Sherif SM, Aquilina AT et al (1998) Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients. Chest 114:138–145
Moore EH (1993) Atypical mycobacterial infection in the lung: CT appearance. Radiology 187:777–782
Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R et al (1989) Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 321:863–868
Al-Houqani M, Jamieson F, Mehta M, Chedore P, May K et al (2012) Aging, COPD, and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario. Chest 141:190–197
Viegas S, Faisca VM, Dias H, Clerigo A, Carolino E et al (2013) Occupational exposure to poultry dust and effects on the respiratory system in workers. J Toxicol Environ Health A 76:230–239
American Thoracic Society Committee of the Scientific Assembly on Environmental and Occupational Health (1997) Adverse effects of crystalline silica exposure. American Thoracic Society Committee of the Scientific Assembly on Environmental and Occupational Health. Am J Respir Crit Care Med 155:761–768
Burgel PR, Bergeron A, de Blic J, Bonniaud P, Bourdin A et al (2013) Small airways diseases, excluding asthma and COPD: an overview. Eur Respir Rev 22:131–147
Billinger ME, Olivier KN, Viboud C, de Oca RM, Steiner C et al (2009) Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998–2005. Emerg Infect Dis 15:1562–1569
Burnett D, Chamba A, Hill SL, Stockley RA (1987) Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 2:1043–1046
Cole PJ (1986) Inflammation: a two-edged sword–the model of bronchiectasis. Eur J Respir Dis Suppl 147:6–15
Martinez-Garcia MA, de la Rosa Carrillo D, Soler-Cataluna JJ, Donat-Sanz Y, Serra PC et al (2013) Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187:823–831
Wickremasinghe M, Ozerovitch LJ, Davies G, Wodehouse T, Chadwick MV et al (2005) Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 60:1045–1051
Lee MR, Yang CY, Chang KP, Keng LT, Yen DH et al (2013) Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease. PLoS One 8:e58214
Huang CT, Tsai YJ, Wu HD, Wang JY, Yu CJ et al (2012) Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 16:539–545
Malcolm KC, Nichols EM, Caceres SM, Kret JE, Martiniano SL et al (2013) Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival. PLoS One 8:e57402
Stockley RA (2013) Bronchiectasis with chronic obstructive pulmonary disease: association or a further phenotype? Am J Respir Crit Care Med 187:786–788
American Thoracic Society (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors Medical Section of the American Lung Association. Am J Respir Crit Care Med 156(2 Pt 2):S1–S25
Chan PC, Yang CH, Chang LY, Wang KF, Kuo YC et al (2013) Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates. Thorax 68:263–268
Daley CL, Griffith DE (2010) Pulmonary non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis 14:665–671
Khan Z, Miller A, Bachan M, Donath J (2010) Mycobacterium avium complex (MAC) lung disease in two inner city community hospitals: recognition, prevalence, co-infection with mycobacterium tuberculosis (MTB) and pulmonary function (PF) Improvements after treatment. Open Respir Med J 4:76–81
Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE (2010) Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 65:956–962
O’Brien C, Guest PJ, Hill SL, Stockley RA (2000) Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 55:635–642
This study was supported in part by Grants (DMR-102-014 and DMR-102-023) from our hospital and the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center for Excellence (DOH102-TD-B-111-004), and the Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence (MOHW103-TD-B-111-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.
Conflict of interest
About this article
Cite this article
Yeh, JJ., Wang, YC., Sung, FC. et al. Nontuberculosis Mycobacterium Disease is a Risk Factor for Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study. Lung 192, 403–411 (2014). https://doi.org/10.1007/s00408-014-9574-9
- Chronic obstructive pulmonary disease
- Nontuberculosis mycobacterium diseases
- National Health Insurance Research Database